Clinical Outcomes and Toxicity in Older Adults Receiving Chimeric Antigen Receptor T Cell Therapy

التفاصيل البيبلوغرافية
العنوان: Clinical Outcomes and Toxicity in Older Adults Receiving Chimeric Antigen Receptor T Cell Therapy
المؤلفون: Johnson, P. Connor, Neckermann, Isabel, Sadrzadeh, Hossein, Newcomb, Richard, El-Jawahri, Areej R., Frigault, Matthew J.
المصدر: Transplantation and Cellular Therapy; May 2024, Vol. 30 Issue: 5 p490-499, 10p
مستخلص: •Age 75+ years was not associated with higher CAR-T toxicity compared to age 65-74.•Age 75+ years was not associated with higher healthcare utilization versus age 65 to 74 years.•We found encouraging rates of overall survival across age categories.•These results support that age alone is not a contraindication for CAR-T.
قاعدة البيانات: Supplemental Index
الوصف
تدمد:26666375
26666367
DOI:10.1016/j.jtct.2024.02.019